Vaccine contains nanoparticles composed of proteins from the surface of the coronavirus
COVID-19 Vaccines Coming for Children Under 5 in June: White House
Federal government has an initial supply of 10 million doses of pediatric vaccines
Pfizer Asks FDA to OK COVID-19 Vaccine for Under 5s
Children younger than 5 years are the only age group in the United States not eligible for COVID-19 vaccination
Vaccination Cuts Risk of Severe COVID-19 in Patients on Dialysis
Reduction in risk of admission and deaths with prior two-dose vaccination versus no vaccination
Lower Risk of COVID-19 in Infants With Vaccination During Pregnancy
Infants of vaccinated mothers had reduced risk of a positive test; risk was lower during delta versus omicron period
Vaccination Offers Partial Protection for Postacute Phase of COVID-19
Individuals with breakthrough infection have increased risk for death, postacute sequelae compared with contemporary controls
Vaccination After SARS-CoV-2 Infection May Cut Long COVID Risk
Initial decrease in odds for long COVID seen after first vaccine dose with evidence suggesting sustained improvement after second dose
Three-Dose Pfizer Vaccine Spurs Strong Response in Youngest Children
Company says third dose gave the young children 80 percent protection against asymptomatic COVID-19
Antibody Levels After COVID-19 Vaccination Inversely Linked to Body Weight
Inverse correlation sustained for up to six months following two doses of BNT162b2 in small cohort of healthy young and middle-aged adults
CDC Advisers Recommend Pfizer Booster Shot for Children 5 to 11
Third shot can be given at least five months after healthy children complete the two-dose vaccine series